ClinicalTrials.Veeva

Menu

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

Anorexia Nervosa

Treatments

Behavioral: Family-Based Treatment (FBT)
Behavioral: Interoceptive Exposure Treatment (IE)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05763849
STUDY-22-01323
1R01MH131655 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight and clinical impairment. Three mechanisms of change (Autonomous Eating, Non-Judgmental Body Awareness, and Extinction Learning) will be examined in a process mediation models of change.

Full description

A total of 120 individuals with Anorexia Nervosa ages 12-18 will be enrolled to either 20 sessions of outpatient Exposure-based Family Therapy (IE) or Family Based Therapy (FBT). The aims of the study are to test the comparative efficacy and primary mechanisms of change after 6 months of treatment and at one year post-treatment and to explore the mediators and moderators of the primary outcomes at these endpoints. All recruitment and study procedures will take place through the Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai. Assessments will take place at 2-, 4-, 6-, 12-, and 18-months following baseline.

Enrollment

120 estimated patients

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 12-18
  • Speak English
  • Permission from pediatrician or equivalent to receive outpatient care
  • Clinically significant restriction of food intake by EDA-5 or evidence of persistent food avoidance from patient or guardians
  • Evidence of the inability to maintain greater than minimally low body weight based on BMI for age percentiles and growth trajectories

Exclusion criteria

  • Comorbid psychotic or bipolar disorder
  • Active suicidal ideation
  • Current substance dependence
  • Psychiatric medication initiated or dosage changes <2 weeks from baseline
  • Major medical illness (e.g., diabetes mellitus, Crohn's disease, etc.)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Interoceptive Exposure Treatment (IE)
Experimental group
Description:
Interoceptive Exposure Therapy (IE) targets food avoidance, food exposure, and body image exposure.
Treatment:
Behavioral: Interoceptive Exposure Treatment (IE)
Family-Based Treatment (FBT)
Active Comparator group
Description:
Family-Based Therapy (FBT) focuses on parent-enforced contingencies, increasing value of eating, and decreasing the value of food avoidance.
Treatment:
Behavioral: Family-Based Treatment (FBT)

Trial contacts and locations

1

Loading...

Central trial contact

Jessica Bibeau, MA; Thomas Hildebrandt, Psy.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems